Joel Habener, Whose Research Led to Weight-Loss Drugs, Dies at 88​

Joel Habener, Whose Research Led to Weight-Loss Drugs, Dies at 88​

RSS » New York Times News » NYTHealth

Joel Habener, Whose Research Led to Weight-Loss Drugs, Dies at 88​

January 10, 2026

New-York-Times-News-rss

 His discovery of the protein fragment GLP-1 was crucial in the development of Ozempic, Wegovy and other blockbuster obesity and diabetes treatments.  

Creator: The New York Times (NYTHealth)

Source URL

Related Posts

  • Events and Conferences
Major One Health Conferences to Attend in September 2026
One Health Conferences September 2026
  • Technology and Digital Health
How AI Pandemic Prediction Could Change Public Health
AI Pandemic Prediction
  • Ecosystems and Health
Biodiversity Protects Health by Reducing Disease Risks
Biodiversity Protects Health

Most Recent

  • Book and Article Reviews
One Health Book Review: A Comprehensive Analysis 
One Health Book Review
  • Careers
Value of MPH in One Health: Career Benefits and Impact
Value of MPH in One Health
  • Community Stories
Malaria Control Strategies: One Health in Action
Malaria Control Community Stories

Spheres of Focus

Infectious Diseases

Climate & Disasters

Food &
Water

Natural
Resources

Built
Environments

Technology & Data

Featured Posts